sharesgurusharesguru
sharesguru
AMRUTANJAN

AMRUTANJAN - Amrutanjan Health Care Limited Share Price

Pharmaceuticals & Biotechnology

722.75-2.55(-0.35%)
Market Closed as of Sep 29, 2025, 15:30 IST

Valuation

Market Cap2.09 kCr
Price/Earnings (Trailing)38.34
Price/Sales (Trailing)4.36
EV/EBITDA25.75
Price/Free Cashflow136.16
MarketCap/EBT28.21
Enterprise Value2.08 kCr

Fundamentals

Revenue (TTM)479.78 Cr
Rev. Growth (Yr)11.7%
Earnings (TTM)54.53 Cr
Earnings Growth (Yr)80.1%

Profitability

Operating Margin15%
EBT Margin15%
Return on Equity16.7%
Return on Assets12.94%
Free Cashflow Yield0.73%

Price to Sales Ratio

Latest reported: 4

Revenue (Last 12 mths)

Latest reported: 48 Cr

Net Income (Last 12 mths)

Latest reported: 55 Cr

Growth & Returns

Price Change 1W-4.8%
Price Change 1M4.9%
Price Change 6M12%
Price Change 1Y-6%
3Y Cumulative Return0.40%
5Y Cumulative Return11.3%
7Y Cumulative Return16.4%
10Y Cumulative Return13%

Cash Flow & Liquidity

Cash Flow from Investing (TTM)-30.97 Cr
Cash Flow from Operations (TTM)50.9 Cr
Cash Flow from Financing (TTM)-13.49 Cr
Cash & Equivalents10.16 Cr
Free Cash Flow (TTM)15.35 Cr
Free Cash Flow/Share (TTM)5.31

Balance Sheet

Total Assets421.39 Cr
Total Liabilities94.77 Cr
Shareholder Equity326.61 Cr
Current Assets290.67 Cr
Current Liabilities84.58 Cr
Net PPE47.73 Cr
Inventory27.26 Cr
Goodwill0.00

Capital Structure & Leverage

Debt Ratio0.00
Debt/Equity0.00
Interest Coverage358.43
Interest/Cashflow Ops247.96

Dividend & Shareholder Returns

Dividend/Share (TTM)4.6
Dividend Yield0.64%
Shares Dilution (1Y)0.00%
Shares Dilution (3Y)-1.1%
Pros

Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.

Buy Backs: Company has bought back it's stock in the past which is a good thing.

Technicals: Bullish SharesGuru indicator.

Profitability: Recent profitability of 11% is a good sign.

Balance Sheet: Strong Balance Sheet.

Cons

Past Returns: Underperforming stock! In past three years, the stock has provided 0.4% return compared to 11.2% by NIFTY 50.

The Good, Bad and Ugly
Growth
Measures how quickly a company is expanding through metrics like revenue growth, earnings growth, and cash flow growth over time. Strong growth can indicate future potential.
Profitability
Shows how efficiently a company turns business activities into profit, using metrics like profit margins, return on equity (ROE), and return on assets (ROA).
Size
Indicates the company's market presence through metrics like market capitalization, total assets, and revenue. Size can influence stability and market influence.
Dilution Rank
Tracks how much the company's shares have increased or decreased over time. Lower dilution means existing shareholders maintain stronger ownership stakes.
Balance Sheet
Evaluates the company's financial health by analyzing assets, debts, and equity. A strong balance sheet indicates financial stability and flexibility.
Momentum
Measures the strength and speed of price movements, showing whether the stock is gaining or losing market favor over different time periods.
Technicals
Analyzes price patterns, trading volumes, and other market indicators to identify potential trading opportunities and market trends.
Smart Money
Tracks the investment activities of institutional investors, hedge funds, and other large financial players who often have deep research capabilities.
Insider Trading
Monitors buying and selling of company shares by executives, directors, and other insiders who may have unique insights into the company's prospects.

Investor Care

Dividend Yield0.64%
Dividend/Share (TTM)4.6
Shares Dilution (1Y)0.00%
Earnings/Share (TTM)18.85

Financial Health

Current Ratio3.44
Debt/Equity0.00

Technical Indicators

RSI (14d)30.21
RSI (5d)0.00
RSI (21d)56.42
MACD SignalSell
Stochastic Oscillator SignalHold
Grufity SignalBuy
RSI SignalHold
RSI5 SignalBuy
RSI21 SignalHold
SMA 5 SignalSell
SMA 10 SignalSell
SMA 20 SignalSell
SMA 50 SignalBuy
SMA 100 SignalBuy

Summary of Latest Earnings Report from Amrutanjan Health Care

Summary of Amrutanjan Health Care's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.

Last updated:

Last updated:

Revenue Breakdown

Analysis of Amrutanjan Health Care's financial performance, highlighting revenue trends, growth patterns, and key metrics through quarterly analysis.

No revenue data available.

Share Holdings

Understand Amrutanjan Health Care ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.

Holding Pattern

Share Holding Details

Shareholder NameHolding %
GOODHEALTH HOLDINGS PRIVATE LIMITED20.15%
SAMBHUPRASAD SIVALENKA10.34%
DSP SMALL CAP FUND5.07%
RAMAA PRABHAKAR ARIKIREVULA4.74%
SAMBHU PRASAD SIVALENKA3.6%
CARNELIAN BHARAT AMRITKAAL FUND2.99%
RAMALINGAM GANTI2.53%
ICICI PRUDENTIAL FMCG FUND2.47%
AMULYA KAMAKSHI PRIYA ARIKIREVULA2.13%
INVESTOR EDUCATION AND PROTECTION FUND AUTHORITY MINISTRY OF CORPORATE AFFAIRS1.34%
DIPAK KANAYALAL SHAH1.09%
CARNELIAN STRUCTURAL SHIFT FUND1.09%

Overall Distribution

Distribution across major stakeholders

Ownership Distribution

Distribution across major institutional holders

Is Amrutanjan Health Care Better than it's peers?

Detailed comparison of Amrutanjan Health Care against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.

Ticker
Name
Mkt Cap
Revenue
Price %, 1M
Returns, 1Y
P/E
P/S
Rev 1-Yr
Inc 1-Yr
MARICOMarico90.85 kCr11.67 kCr-3.40%-54.387.78--
DABURDabur India87.42 kCr13.18 kCr-5.40%-22.10%48.996.63--
PGHHProcter & Gamble Hygiene & Health Care46.14 kCr3.42 kCr+8.60%-13.40%61.7213.5--
EMAMILTDEmami24.17 kCr3.89 kCr-3.40%-26.30%29.556.22--

Sector Comparison: AMRUTANJAN vs Pharmaceuticals & Biotechnology

Comprehensive comparison against sector averages

Comparative Metrics

AMRUTANJAN metrics compared to Pharmaceuticals

CategoryAMRUTANJANPharmaceuticals
PE38.4835.03
PS4.374.93
Growth7.9 %9 %
33% metrics above sector average

Performance Comparison

AMRUTANJAN vs Pharmaceuticals (2021 - 2025)

AMRUTANJAN outperforms the broader Pharmaceuticals sector, although its performance has declined by 23.2% from the previous year.

Key Insights
  • 1. AMRUTANJAN is NOT among the Top 10 largest companies in Pharmaceuticals.
  • 2. The company holds a market share of 0.1% in Pharmaceuticals.
  • 3. The company is growing at an average growth rate of other Pharmaceuticals companies.

Income Statement for Amrutanjan Health Care

Standalone figures (in Rs. Crores)

Balance Sheet for Amrutanjan Health Care

Standalone figures (in Rs. Crores)

Cash Flow for Amrutanjan Health Care

Standalone figures (in Rs. Crores)

What does Amrutanjan Health Care Limited do?

Amrutanjan Health Care is a dynamic Pharmaceuticals company, recognized by its stock ticker, AMRUTANJAN, and boasting a market capitalization of Rs. 1,923 Crores.

The company specializes in manufacturing, supplying, and selling a variety of products including ayurvedic pain balms and women’s hygiene items. It operates through multiple segments: OTC Products, Beverages, and Others.

In the realm of pain management, Amrutanjan produces an array of products such as pain balms, roll-ons, back pain relief roll-ons, stick-on patches, body pain gels, and joint muscle sprays. For congestion management, the company offers cold rubs, cough syrups, nasal inhalers, and swas mints. Additionally, it provides sanitary napkins for women, along with corn caps, dental gels, hand sanitizers, and juice drinks marketed under the Fruitnik and Fruitnik Electro+ brands.

Amrutanjan Health Care also operates a pain management center and exports its products to regions such as the Middle East, Africa, and Southeast Asia.

Originally founded in 1893 and known as Amrutanjan Limited, it rebranded to Amrutanjan Health Care Limited in 2007. The company is headquartered in Chennai, India, and has reported a trailing 12-month revenue of Rs. 461.9 Crores.

Amrutanjan Health Care is profitable, with a profit of Rs. 49.3 Crores reported over the past four quarters. Over the last three years, the company has experienced a commendable revenue growth of 13.7%.

In terms of shareholder returns, Amrutanjan distributes dividends, offering a yield of 0.84% per year, with Rs. 5.6 paid out per share in the last 12 months.

Industry Group:Pharmaceuticals & Biotechnology
Employees:634
Website:www.amrutanjan.com